Immune targets for chemotherapy-resistant breast cancers identified 26 Sep 2022 Researchers perform a deep dive into the different immune markers within tumour tissue and blood samples of early breast cancer patients whose cancer failed to respond to chemotherapy given to them prior to surgery - the findings could help tailor pre-surgical treatment. Find out more Show/Hide
Study shows more women with invasive lobular breast cancer should qualify for tailored clinical trials 30 Mar 2022 A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials. Find out more Show/Hide